Vijay Potluri

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Asana Biosciences, LLC, Dr. Reddy's Laboratories, Incorporated, Asan Biosciences, LLC. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijay Potluri. Retrieved from https://idiyas.com/inventor/vijay-potluri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 33.3

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 16(Granted Patents)

Company Filing History:

6 out of 34

Asana Biosciences, LLC

patents

6 out of 187

Dr. Reddy's Laboratories, Incorporated

patents

1 out of 1

Asan Biosciences, LLC

patent

4. 1 out of 32

Endo Pharmaceuticals Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...

Areas of Expertise:

Quinazolines

Pyrimido-Pyridazinones

Kappa Opioid Receptor

AMPK Activator

Dual Inhibitors

Heterocyclic Compounds

Cancer Pathways

Pharmacology

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10912779 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2021-02-09),

2. 10647720 - Pyrimido-pyridazinone compounds and methods of use thereof (2020-05-12),

3. 10226468 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2019-03-12),

4. 10183944 - Pyrimido-pyridazinone compounds and methods of use thereof (2019-01-22),

5. 10131655 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists (2018-11-20),

6. 9757382 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2017-09-12),

7. 9499495 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2016-11-22),

8. 9487510 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists (2016-11-08),

9. 9382277 - Pyrimido-pyridazinone compounds and methods of use thereof (2016-07-05),

10. 9303027 - Kappa opioid receptor agonists (2016-04-05),

11. 8729079 - Pyrimido-pyridazinone compounds and methods of use thereof (2014-05-20),

12. 8080668 - Thiazoles derivatives as AMPK activator (2011-12-20),

Title: Vijay Potluri - Innovative Inventor from Hyderabad

Introduction: Vijay Potluri is a renowned inventor hailing from Hyderabad, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Vijay Potluri holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare devices.

Career Highlights: With a career spanning over two decades, Vijay Potluri has worked with leading tech companies and research institutions, consistently pushing the boundaries of innovation. His work has been instrumental in shaping the future of technology.

Collaborations: Throughout his career, Vijay Potluri has collaborated with top researchers, engineers, and scientists from around the globe, fostering a culture of innovation and knowledge sharing.

Conclusion: Vijay Potluri's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.